Meeting of the ICD-9-CM Coordination and Maintenance Committee, 11246 [05-4428]
Download as PDF
<![CDATA[
11246
Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices
awareness of the benefits and risks of
new, existing, or combined uses of
therapeutics through education and
research and to reduce costs. The CERTs
were to disseminate their findings to
inform, among others, insurers and
government agencies, patients and
consumers. Under 42 U.S.C. 299b–1(b),
CERTs grantees were to gather, develop
and provide evidence related to
comparative effectiveness, cost
effectiveness and safety of therapeutics.
Thus, the mission and work of the
CERTs is consistent with and addresses
identified priority research
requirements of the MMA section 1013.
Accordingly, the expedite the conduct
of priority research related to health
care services and items including
prescription drugs, as mandated by
section 1013, AHRQ is seeking to carry
out the initial work on a competitive
basis with the benefit of the existing
collaborative organizational frameworks
and therapeutics expertise and
specialization developed by CERTs with
prior AHRQ support.
Review
AHRQ will consider requests from
current CERTs research center grantees
to develop short term supplemental
research projects specifically gathering,
summarizing and assessing available
therapeutics evidence with respect to
subjects identified as priorities pursuant
to MMA section 1013 or formulating
and/or addressing methodological
issues pertinent to the production of
evidence that is needed with research to
these priority subject areas. See https://
www.medicare.gov/MedicareReform/
researchtopics.asp. These competitive
applications for supplemental grant
awards will undergo scientific and
technical review using regular AHRQ
peer review processes. In addition to
criteria set forth in 42 CFR part 67,
subpart A, § 67.15(c), the peer review
evaluations and recommendations, in
particular, will be based on adherence
to the agenda and priorities established
in accordance with section 1013 of the
MMA.
Each center may submit a single
application for supplemental support of
a research project that address clinical
or methodological issues pertaining to a
knowledge gap regarding the
comparative effectiveness of
therapeutics for one or more of the ten
priority clinical areas of interest to the
Medicare, Medicaid and SCHIP
programs. Requests are to be limited to
projects that can be completed in 12
months or less. Although each CERTs
Research Center may be the primary
applicant on any one application,
AHRQ encourages partnerships between
VerDate jul<14>2003
19:54 Mar 07, 2005
Jkt 205001
existing CERTs. The actual number of
applications that will be funded is
dependent on the number of high
quality applications.
Dated: February 24, 2005
Carolyn M. Clancy,
Director.
[FR Doc. 05–4444 Filed 3–7–05; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the ICD–9–CM Coordination
and Maintenance Committee
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff, announces
the following meeting.
Name: ICD–9–CM Coordination and
Maintenance Committee meeting.
Time and Date: 9 a.m.–4 p.m., March
31–April 1, 2005.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland.
Status: Open to the public.
Purpose: The ICD–9–CM Coordination
and Maintenance (C&M) Committee will
hold its first meeting of the 2005
calendar year cycle on Thursday and
Friday March 31–April 1, 2005. The
C&M meeting is a public forum for the
presentation of proposed modifications
to the International Classification of
Diseases, Ninth-Revision, Clinical
Modification.
Matters to be Discussed: Agenda items
include:
Sleep disorders
Epilepsy
Transfusion related lung injury (TRALI)
Failed hearing screening
Myelitis
Macrophage activation syndrome
Subtalar joint arthroereisis
360 degree spinal fusion
Implantation of interspinous process
decompression device
Hip arthroplasty ‘‘bearing surfaces
External fracture fixation devices
Endovascular implantation of graft in
thoracic aorta Infusion of liquid
radioisotope
Radiofrequency Total Occlusion Crossing
System
ICD–10–Procedure Coding System (PCS)
update Addenda
Contact Person for Additional
Information: Amy Blum, Medical
Systems Specialist, Classifications and
Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2402,
Hyattsville, Maryland 20782, telephone
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
(301) 458–4106 (diagnosis), Amy
Gruber, Health Insurance Specialist,
Division of Acute Care, CMS, 7500
Security Blvd., Room C4–07–07,
Baltimore, Maryland 21244 telephone
(410) 786–1542 (procedures).
Notice: Because of increased security
requirements,(CMS) has instituted
stringent procedures for entrance into
the building by non-government
employees. Persons without a
government I.D. will need to show an
official form of picture I.D., (such as a
drivers license), and sign-in at the
security desk upon entering the
building.
Those who wish to attend a specific
ICD–9–CM C&M meeting in the CMS
auditorium must submit their name and
organization for addition to the meeting
visitor list. Those wishing to attend the
March 31–April 1, 2005 meeting must
submit their name and organization by
March 29, 2005 for inclusion on the
visitor list. This visitor list will be
maintained at the front desk of the CMS
building and used by the guards to
admit visitors to the meeting. Those
who attended previous ICD–9–CM C&M
meetings will no longer be
automatically added to the visitor list.
You must request inclusion of your
name prior to each meeting you attend.
Register to attend the meeting on-line at:
https://cms.hhs.gov/events.
Notice: This is a public meeting.
However, because of fire code
requirements, should the number of
attendants meet the capacity of the
room, the meeting will be closed.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: March 2, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–4428 Filed 3–7–05; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Allergenic Products Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
E:\FR\FM\08MRN1.SGM
Notice.
08MRN1
]]>Agencies
[Federal Register Volume 70, Number 44 (Tuesday, March 8, 2005)]
[Notices]
[Page 11246]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4428]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the ICD-9-CM Coordination and Maintenance Committee
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, announces the following meeting.
Name: ICD-9-CM Coordination and Maintenance Committee meeting.
Time and Date: 9 a.m.-4 p.m., March 31-April 1, 2005.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore, Maryland.
Status: Open to the public.
Purpose: The ICD-9-CM Coordination and Maintenance (C&M) Committee
will hold its first meeting of the 2005 calendar year cycle on Thursday
and Friday March 31-April 1, 2005. The C&M meeting is a public forum
for the presentation of proposed modifications to the International
Classification of Diseases, Ninth-Revision, Clinical Modification.
Matters to be Discussed: Agenda items include:
Sleep disorders
Epilepsy
Transfusion related lung injury (TRALI)
Failed hearing screening
Myelitis
Macrophage activation syndrome
Subtalar joint arthroereisis
360 degree spinal fusion
Implantation of interspinous process decompression device
Hip arthroplasty `` bearing surfaces
External fracture fixation devices
Endovascular implantation of graft in thoracic aorta Infusion of
liquid radioisotope
Radiofrequency Total Occlusion Crossing System
ICD-10-Procedure Coding System (PCS) update Addenda
Contact Person for Additional Information: Amy Blum, Medical
Systems Specialist, Classifications and Public Health Data Standards
Staff, NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782,
telephone (301) 458-4106 (diagnosis), Amy Gruber, Health Insurance
Specialist, Division of Acute Care, CMS, 7500 Security Blvd., Room C4-
07-07, Baltimore, Maryland 21244 telephone (410) 786-1542 (procedures).
Notice: Because of increased security requirements,(CMS) has
instituted stringent procedures for entrance into the building by non-
government employees. Persons without a government I.D. will need to
show an official form of picture I.D., (such as a drivers license), and
sign-in at the security desk upon entering the building.
Those who wish to attend a specific ICD-9-CM C&M meeting in the CMS
auditorium must submit their name and organization for addition to the
meeting visitor list. Those wishing to attend the March 31-April 1,
2005 meeting must submit their name and organization by March 29, 2005
for inclusion on the visitor list. This visitor list will be maintained
at the front desk of the CMS building and used by the guards to admit
visitors to the meeting. Those who attended previous ICD-9-CM C&M
meetings will no longer be automatically added to the visitor list. You
must request inclusion of your name prior to each meeting you attend.
Register to attend the meeting on-line at: https://cms.hhs.gov/events.
Notice: This is a public meeting. However, because of fire code
requirements, should the number of attendants meet the capacity of the
room, the meeting will be closed.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: March 2, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-4428 Filed 3-7-05; 8:45 am]
BILLING CODE 4160-18-P
